Latest DrugAffordability News and Updates : DrugAffordability updates, DrugAffordability News , DrugAffordability around the world

Nishadil

Washington | 20°C (overcast clouds)

Europe's Most Favored Nation Drug Pricing Push: A Looming Challenge for Innovation and Access

Top story

Europe's Most Favored Nation Drug Pricing Push: A Looming Challenge for Innovation and Access

In focus

Latest feed

The Prescription Price Revolution: New Players Shake Up Generic Drug Market

Trump's Unprecedented Drug Tariff: A 100% Standoff with Big Pharma

The Persistent Echo: Trump's Most Favored Nation Policy Still Shapes Drug Pricing Debates

A Major Shift? Novo Nordisk Slashes Ozempic and Wegovy Prices

Latest headlines

Rethinking Drug Costs: Why Quick Fixes Might Hurt More Than Help

Rethinking Drug Costs: Why Quick Fixes Might Hurt More Than Help

Unpacking the Trump Administration's Bold Move to Cut Drug Costs

Unpacking the Trump Administration's Bold Move to Cut Drug Costs

The WHO's New Stance on GLP-1s: Guiding the Revolution Responsibly

The WHO's New Stance on GLP-1s: Guiding the Revolution Responsibly

Unlocking Access: The Global Battle for Affordable Medicines

Unlocking Access: The Global Battle for Affordable Medicines

The Weight of Success: Unpacking Novo Nordisk’s Stranglehold on the GLP-1 Market

The Weight of Success: Unpacking Novo Nordisk’s Stranglehold on the GLP-1 Market

The Cost of Cures: Unraveling the High Price Tag on Biologic Drugs and the Persistent Push for Affordability

The Cost of Cures: Unraveling the High Price Tag on Biologic Drugs and the Persistent Push for Affordability

Unlocking Affordability: The FDA's Bold Play to Turbocharge Generic Drug Access

Unlocking Affordability: The FDA's Bold Play to Turbocharge Generic Drug Access

Unlocking Access: The FDA's Bold Move to Fast-Track Life-Saving Biosimilars

Unlocking Access: The FDA's Bold Move to Fast-Track Life-Saving Biosimilars

When States Take on Drug Prices: Connecticut's Bold Move and the Unfolding Legal Drama

When States Take on Drug Prices: Connecticut's Bold Move and the Unfolding Legal Drama

Gilead Halts HIV Drug Price Hikes Amidst Growing Scrutiny and Public Pressure

Gilead Halts HIV Drug Price Hikes Amidst Growing Scrutiny and Public Pressure

The Great Pharmaceutical Reversal: Onshoring's Costly Gamble with Drug Affordability

The Great Pharmaceutical Reversal: Onshoring's Costly Gamble with Drug Affordability

The Perilous Bargain: Are We Trading Future Cures for Today's Drug Savings?

The Perilous Bargain: Are We Trading Future Cures for Today's Drug Savings?

Game Changer: Pfizer Secures Tariff Reprieve, Vows Lower Drug Prices for Millions of Americans

Game Changer: Pfizer Secures Tariff Reprieve, Vows Lower Drug Prices for Millions of Americans

The "TrumpRx" Initiative: A Disruptive Force in the Pharmaceutical Landscape, Challenging Giants Like Pfizer

The "TrumpRx" Initiative: A Disruptive Force in the Pharmaceutical Landscape, Challenging Giants Like Pfizer

Trump's Tariff Vision: A Risky Prescription for Soaring Drug Costs and Shaken Supply Chains

Trump's Tariff Vision: A Risky Prescription for Soaring Drug Costs and Shaken Supply Chains

Eli Lilly Declares UK 'Worst in Europe' for Drug Prices, Threatening Patient Access to New Medicines

Eli Lilly Declares UK 'Worst in Europe' for Drug Prices, Threatening Patient Access to New Medicines

Historic Triumph for American Patients: Pharma Giant Levels Drug Prices Across US and Europe Following Trump's Relentless Advocacy

Historic Triumph for American Patients: Pharma Giant Levels Drug Prices Across US and Europe Following Trump's Relentless Advocacy

WHO's Landmark Move: Adding Diabetes and Weight Loss Drugs to Essential Medicines List Sparks Hope and Debate

WHO's Landmark Move: Adding Diabetes and Weight Loss Drugs to Essential Medicines List Sparks Hope and Debate

The GLP-1 Dilemma: Insurers Grapple with Soaring Costs, Eyeing New Strategies for Patient Care

The GLP-1 Dilemma: Insurers Grapple with Soaring Costs, Eyeing New Strategies for Patient Care

Life-Saving Cancer Drugs Out of Reach: India's Price Control Gap Leaves Patients Vulnerable

Life-Saving Cancer Drugs Out of Reach: India's Price Control Gap Leaves Patients Vulnerable

Load more